Dr.Reddys Laboratories reported INR54.75B in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Aspen Pharmacare APN:SJ 19.38B 248M
Bharat Petroleum BPCL:IN 1232.17B 55.15B
Cipla CIPLA:IN IR 52603.3M 2185.3M
Dr.Reddys Laboratories DRRD:IN IR 54749M 1366M
Reliance Infra RELI:IN IR 2118870M 206160M
Sun Pharmaceuticals SUNP:IN IR 94467.6M 4163M
UPL UPLL:IN IR 158610M 45640M